| 000 | 01615 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517233737.0 | ||
| 264 | 0 | _c20191113 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1549-490X | ||
| 024 | 7 |
_a10.1634/theoncologist.2017-0498 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBasho, Reva K | |
| 245 | 0 | 0 |
_aComparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer. _h[electronic resource] |
| 260 |
_bThe oncologist _c11 2018 |
||
| 300 |
_a1300-1309 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aYam, Clinton | |
| 700 | 1 | _aGilcrease, Michael | |
| 700 | 1 | _aMurthy, Rashmi K | |
| 700 | 1 | _aHelgason, Thorunn | |
| 700 | 1 | _aKarp, Daniel D | |
| 700 | 1 | _aMeric-Bernstam, Funda | |
| 700 | 1 | _aHess, Kenneth R | |
| 700 | 1 | _aValero, Vicente | |
| 700 | 1 | _aAlbarracin, Constance | |
| 700 | 1 | _aLitton, Jennifer K | |
| 700 | 1 | _aChavez-MacGregor, Mariana | |
| 700 | 1 | _aHong, David | |
| 700 | 1 | _aKurzrock, Razelle | |
| 700 | 1 | _aHortobagyi, Gabriel N | |
| 700 | 1 | _aJanku, Filip | |
| 700 | 1 | _aMoulder, Stacy L | |
| 773 | 0 |
_tThe oncologist _gvol. 23 _gno. 11 _gp. 1300-1309 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.2017-0498 _zAvailable from publisher's website |
| 999 |
_c28761344 _d28761344 |
||